At Children’s Healthcare of Atlanta, our researchers partner with colleagues at Emory University School of Medicine to improve the treatment and quality of life of children with liver disease.
We’re committed to being at the forefront of liver transplant research. Our researchers are involved in a number of collaborative efforts that further our efforts and expand our understanding of liver disease in children.
Our areas of interest for research include:
- Acute liver failure.
- Adolescent transplant patients’ adherence to their medication and lifestyle regimen and transitioning them from pediatric- to adult-centered care.
- Biliary atresia, a rare disease of the liver and bile ducts that occurs in infants.
- Cystic fibrosis, a lung disease that causes blockages in the liver’s bile ducts.
- Fatty liver disease.
- Hepatitis B and C therapy in children.
- Post-transplantation medical issues.
- Neonatal alloimmune liver disease, a rare condition in which iron accumulates in a baby’s liver during development in the womb.
- Neonatal cholestatic liver disease, a bile formation or bile flow impairment that damages a baby’s liver tissue.
- Noninvasive diagnosis of liver disease using MRI.
- Nutritional status after liver transplantation.
- Portal hypertension, an increase in the blood pressure within the portal venous system (veins and vessels that travel through the digestive system).
- Transplant rejection and immunologic tolerance (acceptance by the body).